Cargando…

NFATc1 Regulation of TRAIL Expression in Human Intestinal Cells

TNF-related apoptosis-inducing ligand (TRAIL; Apo2) has been shown to promote intestinal cell differentiation. Nuclear factor of activated T cells (NFAT) participates in the regulation of a variety of cellular processes, including differentiation. Here, we examined the role of NFAT in the regulation...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qingding, Zhou, Yuning, Weiss, Heidi L., Chow, Chi-Wing, Evers, B. Mark
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095616/
https://www.ncbi.nlm.nih.gov/pubmed/21603612
http://dx.doi.org/10.1371/journal.pone.0019882
_version_ 1782203674544570368
author Wang, Qingding
Zhou, Yuning
Weiss, Heidi L.
Chow, Chi-Wing
Evers, B. Mark
author_facet Wang, Qingding
Zhou, Yuning
Weiss, Heidi L.
Chow, Chi-Wing
Evers, B. Mark
author_sort Wang, Qingding
collection PubMed
description TNF-related apoptosis-inducing ligand (TRAIL; Apo2) has been shown to promote intestinal cell differentiation. Nuclear factor of activated T cells (NFAT) participates in the regulation of a variety of cellular processes, including differentiation. Here, we examined the role of NFAT in the regulation of TRAIL in human intestinal cells. Treatment with a combination of phorbol 12-myristate 13-acetate (PMA) plus the calcium ionophore A23187 (Io) increased NFAT activation and TRAIL expression; pretreatment with the calcineurin inhibitor cyclosporine A (CsA), an antagonist of NFAT signaling, diminished NFAT activation and TRAIL induction. In addition, knockdown of NFATc1, NFATc2, NFATc3, and NFATc4 blocked PMA/Io increased TRAIL protein expression. Expression of NFATc1 activated TRAIL promoter activity and increased TRAIL mRNA and protein expression. Deletion of NFAT binding sites from the TRAIL promoter did not significantly abrogate NFATc1-increased TRAIL promoter activity, suggesting an indirect regulation of TRAIL expression by NFAT activation. Knockdown of NFATc1 increased Sp1 transcription factor binding to the TRAIL promoter and, importantly, inhibition of Sp1, by chemical inhibition or RNA interference, increased TRAIL expression. These studies identify a novel mechanism for TRAIL regulation by which activation of NFATc1 increases TRAIL expression through negative regulation of Sp1 binding to the TRAIL promoter.
format Text
id pubmed-3095616
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-30956162011-05-19 NFATc1 Regulation of TRAIL Expression in Human Intestinal Cells Wang, Qingding Zhou, Yuning Weiss, Heidi L. Chow, Chi-Wing Evers, B. Mark PLoS One Research Article TNF-related apoptosis-inducing ligand (TRAIL; Apo2) has been shown to promote intestinal cell differentiation. Nuclear factor of activated T cells (NFAT) participates in the regulation of a variety of cellular processes, including differentiation. Here, we examined the role of NFAT in the regulation of TRAIL in human intestinal cells. Treatment with a combination of phorbol 12-myristate 13-acetate (PMA) plus the calcium ionophore A23187 (Io) increased NFAT activation and TRAIL expression; pretreatment with the calcineurin inhibitor cyclosporine A (CsA), an antagonist of NFAT signaling, diminished NFAT activation and TRAIL induction. In addition, knockdown of NFATc1, NFATc2, NFATc3, and NFATc4 blocked PMA/Io increased TRAIL protein expression. Expression of NFATc1 activated TRAIL promoter activity and increased TRAIL mRNA and protein expression. Deletion of NFAT binding sites from the TRAIL promoter did not significantly abrogate NFATc1-increased TRAIL promoter activity, suggesting an indirect regulation of TRAIL expression by NFAT activation. Knockdown of NFATc1 increased Sp1 transcription factor binding to the TRAIL promoter and, importantly, inhibition of Sp1, by chemical inhibition or RNA interference, increased TRAIL expression. These studies identify a novel mechanism for TRAIL regulation by which activation of NFATc1 increases TRAIL expression through negative regulation of Sp1 binding to the TRAIL promoter. Public Library of Science 2011-05-16 /pmc/articles/PMC3095616/ /pubmed/21603612 http://dx.doi.org/10.1371/journal.pone.0019882 Text en Wang et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Wang, Qingding
Zhou, Yuning
Weiss, Heidi L.
Chow, Chi-Wing
Evers, B. Mark
NFATc1 Regulation of TRAIL Expression in Human Intestinal Cells
title NFATc1 Regulation of TRAIL Expression in Human Intestinal Cells
title_full NFATc1 Regulation of TRAIL Expression in Human Intestinal Cells
title_fullStr NFATc1 Regulation of TRAIL Expression in Human Intestinal Cells
title_full_unstemmed NFATc1 Regulation of TRAIL Expression in Human Intestinal Cells
title_short NFATc1 Regulation of TRAIL Expression in Human Intestinal Cells
title_sort nfatc1 regulation of trail expression in human intestinal cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095616/
https://www.ncbi.nlm.nih.gov/pubmed/21603612
http://dx.doi.org/10.1371/journal.pone.0019882
work_keys_str_mv AT wangqingding nfatc1regulationoftrailexpressioninhumanintestinalcells
AT zhouyuning nfatc1regulationoftrailexpressioninhumanintestinalcells
AT weissheidil nfatc1regulationoftrailexpressioninhumanintestinalcells
AT chowchiwing nfatc1regulationoftrailexpressioninhumanintestinalcells
AT eversbmark nfatc1regulationoftrailexpressioninhumanintestinalcells